These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8924366)

  • 21. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
    Nichols KE; Malkin D; Garber JE; Fraumeni JF; Li FP
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):83-7. PubMed ID: 11219776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk assessment for familial occurrence of breast cancer].
    Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
    Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic testing for cancer susceptibility: challenges for creators of practice guidelines.
    Greely HT
    Oncology (Williston Park); 1997 Nov; 11(11A):171-6. PubMed ID: 9430188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the genetic counselor in familial cancer.
    Peters JA; Stopfer JE
    Oncology (Williston Park); 1996 Feb; 10(2):159-66, 175; discussion 176-6, 178,. PubMed ID: 8838258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer genetics in primary care.
    Culler D; Grimes SJ; Acheson LS; Wiesner GL
    Prim Care; 2004 Sep; 31(3):649-83, xi. PubMed ID: 15331253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial distribution of patient population and family physician endorsed importance of screening patients for inherited predisposition to cancer.
    Gramling R; Clarke J; Simmons E
    J Health Care Poor Underserved; 2009 Feb; 20(1):50-4. PubMed ID: 19202245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?
    Achatz MI; Hainaut P; Ashton-Prolla P
    Lancet Oncol; 2009 Sep; 10(9):920-5. PubMed ID: 19717094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
    Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
    Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic susceptibility to cancer].
    Stoica O; Sandovici I; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):21-30. PubMed ID: 12089987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.
    Brierley KL; Blouch E; Cogswell W; Homer JP; Pencarinha D; Stanislaw CL; Matloff ET
    Cancer J; 2012; 18(4):303-9. PubMed ID: 22846730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing.
    Foulkes WD; Narod SA
    Clin Invest Med; 1995 Dec; 18(6):473-83. PubMed ID: 8714791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical aspects of delivering hereditary cancer risk counseling.
    DeMarco TA; Smith KL; Nusbaum RH; Peshkin BN; Schwartz MD; Isaacs C
    Semin Oncol; 2007 Oct; 34(5):369-78. PubMed ID: 17920890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene testing for cancer susceptibility.
    Reiser G; Schaefer GB
    Nebr Med J; 1996 Dec; 81(12):416-8. PubMed ID: 9046792
    [No Abstract]   [Full Text] [Related]  

  • 34. [Familial colorectal cancer].
    Sunde LE; Bülow S; Bernstein IT
    Ugeskr Laeger; 2006 Jun; 168(24):2369-73. PubMed ID: 16822423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversies and ethical issues in cancer-genetics clinics.
    Harris M; Winship I; Spriggs M
    Lancet Oncol; 2005 May; 6(5):301-10. PubMed ID: 15863378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to control cancer through genetics.
    Berg K
    Princess Takamatsu Symp; 1987; 18():283-94. PubMed ID: 3333497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic testing in gastroenterology: Lynch syndrome.
    Grover S; Syngal S
    Best Pract Res Clin Gastroenterol; 2009; 23(2):185-96. PubMed ID: 19414145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
    Robson ME; Storm CD; Weitzel J; Wollins DS; Offit K;
    J Clin Oncol; 2010 Feb; 28(5):893-901. PubMed ID: 20065170
    [No Abstract]   [Full Text] [Related]  

  • 39. How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey.
    Graham ID; Logan DM; Hughes-Benzie R; Evans WK; Perras H; McAuley LM; Laupacis A; Stern H
    Cancer Prev Control; 1998 Aug; 2(4):167-72. PubMed ID: 10093629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hereditary neoplastic diseases (genetic predisposition and cancer syndromes)].
    Oláh E
    Orv Hetil; 1999 Feb; 140(9):451-66. PubMed ID: 10204401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.